Eley, John G.
Chadha, Awalpreet S.
Quini, Caio
Vichaya, Elisabeth G.
Zhang, Cancan
Davis, James
Sahoo, Narayan
Waddell, Jaylyn
Leiser, Dominic
Dilmanian, F. Avraham
Krishnan, Sunil
Funding for this research was provided by:
Swiss Cancer Research Foundation
MD Anderson Cancer Center Support Grant
John E and Dorothy J Harris Endowment Professorship
Article History
Received: 26 November 2019
Accepted: 24 April 2020
First Online: 9 July 2020
Competing interests
: J.G.E., F.A.D. and S.K. are on a patent on proton minibeams with the University of Texas Board of Regents and Stony Brook Medicine as assignees. Other authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper. Drs. Eley, Dilmanian, and Krishnan hold a patent related to proton minibeam therapy: US Patent 9962556 B2. Drs. Quini, Vichaya, Zhang, Davis, Sahoo, Waddell, and Leiser declare no potential conflict of interest.